IGFBP-1
IGFBP-1 (insulin-like growth factor-binding protein 1, also known as IGF-BP25, AFBP, hIGFBP-1, PP12 and IBP1) is a secreted protein that regulates how much IGF-I and IGF-II is available to cell surface receptors. It also contributes to cell migration and metabolism. Browse Assay Genie's current range of IGFBP-1 research reagents below, or read on for the biology behind the target.
IGFBP-1 is a multifunctional protein that controls the availability of IGFs, such as IGF1 and IGF2, to their receptors. In doing so it influences IGF-mediated cellular processes including cell migration, proliferation, differentiation and apoptosis, in a cell-type specific manner. The protein circulates in the plasma and binds both IGF-I and IGF-II, which prolongs their half-lives and alters their interaction with cell surface receptors.
IGFBP-1 also acts independently of IGF binding. Through its RGD motif it interacts with the integrin ITGA5:ITGB1, and this binding activates focal adhesion kinase (PTK2) and stimulates the mitogen-activated protein kinase (MAPK) pathway, giving the protein a positive role in cell migration. In cardiomyocytes, IGFBP-1 regulates apoptosis by suppressing the ubiquitination and subsequent degradation of HIF-1alpha (HIF1A).
The IGFBP1 gene is a member of the insulin-like growth factor binding protein family and encodes a protein with an IGFBP N-terminal domain and a thyroglobulin type-I domain. The protein is mainly expressed in the liver. Low levels have been associated with impaired glucose tolerance, vascular disease and hypertension in human patients. The HGNC places the gene in the insulin like growth factor binding proteins group, and mouse and rat each have an Igfbp1 ortholog.
IGFBP-1 modulates the availability of IGF-I and IGF-II to their receptors, making it central to studies of IGF-regulated cell processes.
Through its RGD motif and integrin ITGA5:ITGB1, IGFBP-1 activates PTK2 and MAPK signalling to promote cell migration.
IGFBP-1 is important in metabolism, and low levels are associated with impaired glucose tolerance in human patients.
Low IGFBP-1 is linked to vascular disease and hypertension, and the protein regulates cardiomyocyte apoptosis through HIF-1alpha stability.
IGFBP-1 regulates the availability of IGF1 and IGF2 to their receptors, thereby affecting cell migration, proliferation, differentiation and apoptosis. It prolongs IGF half-lives in plasma. It also binds integrin ITGA5:ITGB1 via its RGD motif, activating PTK2 and the MAPK pathway.
The IGFBP1 gene product is also called IGF-BP25, AFBP, hIGFBP-1, PP12 and IBP1. The HGNC name is insulin like growth factor binding protein 1, and UniProt lists it as insulin-like growth factor-binding protein 1. These names all refer to the same secreted protein.
Low IGFBP-1 levels may be associated with impaired glucose tolerance, vascular disease and hypertension in humans. Mouse and rat both have an Igfbp1 ortholog. Check the datasheet of any product for its validated reactivity.
Other members of the insulin-like growth factor binding protein family with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P08833; product specifications from Assay Genie datasheets.